Did Biomea Fusion, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - BMEA
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biomea Fusion, Inc. ("Biomea Fusion, Inc.") (NASDAQ:BMEA) concerning possible violations of federal securities laws. Biomea issued a press release on June 6, 2024, announcing that it "has received notice from the U.S. Food and Drug Administration (FDA) that a full clinical hold has been placed on Biomea's ongoing Phase I/II clinical trials of the Company's investigational covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes (COVALENT-111 and COVALENT-112), respectively.
The Schall Law Firm Is Looking Into Potential Securities Law Violations By Biomea Fusion Inc And Encourages Shareholders To Help
LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Is Looking Into Potential Securities Violations By Biomea Fusion Inc And Encourages Investors To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Is Investigating Biomea Fusion Inc And Invites Investors With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Is Investigating Claims Against Biomea Fusion Inc And Asks Shareholders With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Investigates Claims Against Biomea Fusion Inc And Encourages Investors With Losses To Initiate Contact
LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Initiates An Investigation Into Claims Against Biomea Fusion Inc And Urges Shareholders With Losses To Get In Touch
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
Wall Street Analysts Think Biomea Fusion (BMEA) Could Surge 317.86%: Read This Before Placing a Bet
The consensus price target hints at a 317.9% upside potential for Biomea Fusion (BMEA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The Schall Law Firm Initiates An Investigation Into Allegations Against Biomea Fusion Inc And Motivates Shareholders With Losses To Contact
LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Initiates An Investigation Into Claims Against Biomea Fusion Inc And Invites Shareholders With Losses To Reach Out
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Initiates An Investigation Into Allegations Against Biomea Fusion Inc And Invites Shareholders With Losses To Contact
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
The Schall Law Firm Begins A Probe Into Claims Against Biomea Fusion Inc And Encourages Shareholders With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc.. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws.
